Form 8-K - Current report:
SEC Accession No. 0001140361-25-021024
Filing Date
2025-06-02
Accepted
2025-06-02 06:21:02
Documents
24
Period of Report
2025-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20050047_8k.htm   iXBRL 8-K 76407
2 EXHIBIT 2.1 ef20050047_ex2-1.htm EX-2.1 872898
3 EXHIBIT 10.1 ef20050047_ex10-1.htm EX-10.1 54264
4 EXHIBIT 10.2 ef20050047_ex10-2.htm EX-10.2 57361
5 EXHIBIT 10.3 ef20050047_ex10-3.htm EX-10.3 37470
6 EXHIBIT 10.4 ef20050047_ex10-4.htm EX-10.4 30772
7 EXHIBIT 10.5 ef20050047_ex10-5.htm EX-10.5 76688
8 EXHIBIT 10.6 ef20050047_ex10-6.htm EX-10.6 69352
9 EXHIBIT 10.7 ef20050047_ex10-7.htm EX-10.7 78429
10 EXHIBIT 10.8 ef20050047_ex10-8.htm EX-10.8 145345
11 EXHIBIT 99.1 ef20050047_ex99-1.htm EX-99.1 35562
15 image00001.jpg GRAPHIC 2905
16 image00002.jpg GRAPHIC 2855
  Complete submission text file 0001140361-25-021024.txt   1985981

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA atai-20250602.xsd EX-101.SCH 3856
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20250602_lab.xml EX-101.LAB 22690
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20250602_pre.xml EX-101.PRE 16546
26 EXTRACTED XBRL INSTANCE DOCUMENT ef20050047_8k_htm.xml XML 4213
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 251013055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)